<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03174132</url>
  </required_header>
  <id_info>
    <org_study_id>43TW1628</org_study_id>
    <nct_id>NCT03174132</nct_id>
  </id_info>
  <brief_title>Pain and Safety of Restylane Perlane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds</brief_title>
  <official_title>A Randomised, Multi-center, Subject and Evaluator-blinded Study Comparing the Pain and the Safety Profile Associate With Correction of Moderate to Severe Nasolabial Folds Using Restylane Perlane Lidocaine Compared to Restylane Perlane</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Q-Med AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Q-Med AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the pain and safety in associated with injection of
      Restylane Perlane Lidocaine compared to Restylane Perlane using VAS scale
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2017</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Differences in Pain (Restylane Perlane Lidocaine side - Restylane Perlane side) as measured by a Visual Analogue Scale (VAS)</measure>
    <time_frame>Up to 60 minutes after injection on day 1</time_frame>
    <description>No pain is noted at 0 mm and worst pain is noted at 100 mm</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Nasolabial Fold</condition>
  <arm_group>
    <arm_group_label>Restylane Perlane Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Restylane Perlane Lidocaine will be injected into one side of the nasolabial fold at day 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Restylane Perlane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Restylane Perlane will be injected into the opposite side of the nasolabial fold on day 1</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restylane Perlane Lidocaine</intervention_name>
    <description>Intradermal injection</description>
    <arm_group_label>Restylane Perlane Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restylane Perlane</intervention_name>
    <description>Intradermal injection</description>
    <arm_group_label>Restylane Perlane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed and dated informed consent to participate in the study.

          -  Men or women aged 20 years or older of Chinese origin.

          -  Subjects willing to abstain from any other facial plastic surgical or cosmetic
             procedures below the level of the lower orbital rim for the duration of the study.

          -  Intent to undergo correction of both nasolabial folds (NLF) with a wrinkle severity in
             Wrinkle Severity Rating Scale (WSRS) of either grade 3 on both NLFs or grade 4 on both
             NLFs.

        Exclusion Criteria:

          -  Previous tissue augmentation therapy or contouring with any permanent
             (non-biodegradable) or semi-permanent filler, autologous fat, lifting threads or
             permanent implant below the level of the lower orbital rim.

          -  Previous use of any hyaluronic acid based or collagen based biodegradable facial
             tissue augmentation therapy below the level of the lower orbital rim within 12 months
             before treatment.

          -  Previous tissue revitalization treatment with laser or light, mesotherapy,
             radiofrequency, ultrasound, cryotherapy, chemical peeling or dermabrasion in the
             midface within 6 months before treatment.

          -  Scars or deformities, active skin disease, inflammation or related conditions near or
             in the area to be treated.

          -  Other condition preventing the subject from entering the study in the Investigator's
             opinion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Q-Med AB</last_name>
    <role>Study Director</role>
    <affiliation>Q-Med AB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Q-Med AB</last_name>
    <phone>+46 18 474 9000</phone>
    <email>Q-Med@galderma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Q-Med AB</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kaohsiung Medical University</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Taipei Medical University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2017</study_first_submitted>
  <study_first_submitted_qc>June 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2017</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

